An accurate prognostic prediction for aneurysmal subarachnoid hemorrhage dedicated to patients after endovascular treatment.

Authors:
Lu H; Xue G; Li S; Mu Y; Xu Y and 9 more

Journal:
Ther Adv Neurol Disord

Publication Year: 2022

DOI:
10.1177/17562864221099473

PMCID:
PMC9168851

PMID:
35677817

Journal Information

Full Title: Ther Adv Neurol Disord

Abbreviation: Ther Adv Neurol Disord

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Clinical Neurology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest statement: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: J.L, Y.Z, Q.L., P.Y., G.X., and H.L. are listed as inventors on submitted patents on prognostic prediction model using machine learning. The other authors declare no conflict of interest."

Evidence found in paper:

"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was partially supported by grants from the National Key Research and Development Program of China (No. 2019YFA0709502), the National Natural Science Foundation of China (No. 81873909 and 81930095), the Science and Technology Commission of Shanghai Municipality (No. 20ZR1404900 and 20DZ2260300), the Shanghai Municipal Science and Technology Major Project (No.s 2018SHZDZX01 and 2021SHZDZX0103), the Fundamental Research Funds for the Central Universities, the SanHang Program of the Naval Medical University, and the ‘Climbing’ program of Changhai hospital, the National Research and Development Project of Key Chronic Diseases."

Evidence found in paper:

"Ethics Statement: The study protocol was approved by the Shanghai Changhai Hospital Ethics Committee (Registration no. CHEC2017-074). Because of the retrospective nature of the analysis with pseudonymised patient data, separate informed consent was waived by the committee. This corresponds to the local legislation."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025